Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.39 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.39 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | RARB | P10826 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5038982 | 0.84 | NPC1 (0.50) | CYP1A2PTGS1LMNATSHRSIGMAR1 | |
| SCHEMBL457465 | 0.74 | TBXAS1 (0.51) | CYP1A2CYP2D6PMP22APEX1PTGS1 | |
| SCHEMBL9910745 | 0.74 | TBXAS1 (0.51) | CYP1A2CYP2D6PMP22APEX1PTGS1 | |
| SCHEMBL12639935 | 0.74 | TBXAS1 (0.51) | CYP1A2CYP2D6PMP22APEX1PTGS1 | |
| SCHEMBL6869156 | 0.71 | LDHA (0.57) | CYP1A2CYP2D6PTGS1PTGS2LMNA | |
| SCHEMBL14019341 | 0.71 | CYP1A2 (0.48) | CYP1A2CYP2D6PMP22APEX1PTGS1 | |
| SCHEMBL10151312 | 0.71 | RXRA (0.50) | RXRARXRB | |
| SCHEMBL5998701 | 0.70 | RXRA (0.46) | CYP1A2CYP2D6CYP2C9RXRARXRB | |
| SCHEMBL2718708 | 0.70 | RXRA (0.46) | CYP1A2CYP2D6CYP2C9RXRARXRB | |
| SCHEMBL1066034 | 0.70 | CYP1A2 (0.49) | CYP1A2CYP2D6PMP22APEX1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11957664-B2 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-04-16 | — | — | US | disclosed |
| US-20230263776-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-08-24 | — | — | US | disclosed |
| US-20230241032-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-08-03 | — | — | US | disclosed |
| US-20230014787-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-01-19 | — | — | US | disclosed |
| US-11324723-B2 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-05-10 | — | — | US | disclosed |
| US-11116753-B2 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2021-09-14 | — | — | US | disclosed |
| US-20210023058-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA | 2021-01-28 | — | — | US | disclosed |
| US-20200316028-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA | 2020-10-08 | — | — | US | disclosed |
| US-10603307-B2 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2020-03-31 | — | — | US | disclosed |
| EP-2801625-B1 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | UNIV VIRGINIA PATENT FOUNDATION (US) | 2017-11-01 | — | — | EP | disclosed |
| US-20170239222-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA | 2017-08-24 | — | — | US | disclosed |
| US-9539242-B2 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2017-01-10 | — | — | US | disclosed |
| EP-2801625-A1 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | University Of Virginia (US) | 2014-11-12 | — | — | EP | disclosed |
| US-20140288139-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA | 2014-09-25 | — | — | US | disclosed |
| US-8753815-B2 | Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2014-06-17 | — | — | US | disclosed |
| EP-2588630-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | University Of Virginia Patent Foundation (US) | 2013-05-08 | — | — | EP | disclosed |
| US-20130012559-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2013-01-10 | — | — | US | disclosed |
| US-20120115149-A1 | SEROTONIN TRANSPORTER GENE AND TREATMENT OF ALCOHOLISM | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2012-05-10 | — | — | US | disclosed |
| WO-2012003462-A1 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | JOHNSON BANKOLE A (US) | 2012-01-05 | — | — | WO | disclosed |
| CN-101014359-A | Method of treating parkinson's disease in humans by direct infusion of glial cell-line derived neurotrophic factor into the zona incerta | RENISHAW PLC (GB) | 2007-08-08 | — | — | CN | disclosed |